 James Costello
Concepts (422)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder Neoplasms | 12 | 2024 | 226 | 2.910 |
Why?
| | Cisplatin | 4 | 2024 | 298 | 1.640 |
Why?
| | Drug Resistance, Neoplasm | 8 | 2024 | 750 | 1.590 |
Why?
| | Computational Biology | 10 | 2025 | 598 | 1.550 |
Why?
| | Gene Expression Profiling | 10 | 2024 | 1689 | 1.380 |
Why?
| | Down Syndrome | 4 | 2025 | 471 | 1.310 |
Why?
| | Algorithms | 13 | 2018 | 1621 | 1.240 |
Why?
| | Antineoplastic Agents | 9 | 2024 | 2060 | 1.160 |
Why?
| | Cell Line, Tumor | 21 | 2025 | 3184 | 1.000 |
Why?
| | Transcriptome | 8 | 2024 | 883 | 0.890 |
Why?
| | Biomarkers, Tumor | 5 | 2022 | 1185 | 0.860 |
Why?
| | Gene Regulatory Networks | 6 | 2023 | 281 | 0.850 |
Why?
| | Neoplasms | 9 | 2024 | 2475 | 0.770 |
Why?
| | Prostatic Neoplasms | 4 | 2023 | 1013 | 0.770 |
Why?
| | Crowdsourcing | 5 | 2023 | 18 | 0.760 |
Why?
| | Computer Simulation | 5 | 2018 | 941 | 0.750 |
Why?
| | Premature Birth | 2 | 2023 | 312 | 0.730 |
Why?
| | Cell-Free Nucleic Acids | 1 | 2021 | 31 | 0.720 |
Why?
| | Gene Expression Regulation, Neoplastic | 15 | 2025 | 1353 | 0.710 |
Why?
| | Blood Proteins | 1 | 2021 | 240 | 0.640 |
Why?
| | Pre-Eclampsia | 1 | 2021 | 185 | 0.630 |
Why?
| | MutS Homolog 2 Protein | 1 | 2018 | 13 | 0.620 |
Why?
| | Chromosomes, Human | 1 | 2018 | 41 | 0.610 |
Why?
| | Pharmaceutical Preparations | 1 | 2020 | 170 | 0.610 |
Why?
| | Fluorescence | 1 | 2018 | 158 | 0.590 |
Why?
| | Gestational Age | 1 | 2021 | 868 | 0.580 |
Why?
| | Whole Genome Sequencing | 1 | 2018 | 131 | 0.580 |
Why?
| | Tripartite Motif Proteins | 1 | 2017 | 31 | 0.570 |
Why?
| | Transcription Factors | 4 | 2022 | 1632 | 0.570 |
Why?
| | CRISPR-Cas Systems | 1 | 2018 | 110 | 0.570 |
Why?
| | Models, Biological | 4 | 2018 | 1695 | 0.560 |
Why?
| | Metabolic Networks and Pathways | 1 | 2018 | 175 | 0.550 |
Why?
| | Genetic Loci | 1 | 2018 | 274 | 0.550 |
Why?
| | Homeodomain Proteins | 5 | 2023 | 493 | 0.520 |
Why?
| | Body Mass Index | 1 | 2025 | 2266 | 0.520 |
Why?
| | Breast Neoplasms | 5 | 2021 | 2150 | 0.520 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2017 | 153 | 0.520 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 5 | 2023 | 1573 | 0.500 |
Why?
| | Genomics | 6 | 2023 | 716 | 0.480 |
Why?
| | Telomerase | 4 | 2020 | 231 | 0.460 |
Why?
| | MAP Kinase Kinase Kinases | 3 | 2021 | 71 | 0.450 |
Why?
| | Triple Negative Breast Neoplasms | 3 | 2025 | 191 | 0.450 |
Why?
| | Humans | 62 | 2025 | 129126 | 0.440 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2018 | 737 | 0.440 |
Why?
| | Competitive Behavior | 1 | 2013 | 41 | 0.410 |
Why?
| | Oligonucleotide Array Sequence Analysis | 7 | 2016 | 757 | 0.400 |
Why?
| | DNA-Binding Proteins | 6 | 2022 | 1423 | 0.390 |
Why?
| | Chromosomes, Human, Pair 21 | 2 | 2025 | 42 | 0.390 |
Why?
| | Receptors, Androgen | 3 | 2021 | 143 | 0.390 |
Why?
| | Obesity | 1 | 2025 | 2863 | 0.370 |
Why?
| | Carcinoma, Transitional Cell | 3 | 2017 | 60 | 0.370 |
Why?
| | Cooperative Behavior | 2 | 2016 | 427 | 0.370 |
Why?
| | Biomedical Research | 2 | 2016 | 647 | 0.350 |
Why?
| | Drosophila | 3 | 2008 | 143 | 0.350 |
Why?
| | Rhabdomyosarcoma | 2 | 2022 | 64 | 0.350 |
Why?
| | Cadherins | 3 | 2024 | 186 | 0.330 |
Why?
| | Lung Neoplasms | 3 | 2018 | 2329 | 0.330 |
Why?
| | Mutation | 7 | 2023 | 3700 | 0.320 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2023 | 266 | 0.320 |
Why?
| | Zebrafish Proteins | 2 | 2022 | 269 | 0.310 |
Why?
| | Protein Interaction Mapping | 1 | 2009 | 109 | 0.310 |
Why?
| | Animals | 30 | 2025 | 34600 | 0.310 |
Why?
| | Neoplasm Metastasis | 6 | 2025 | 616 | 0.290 |
Why?
| | Protein Tyrosine Phosphatases | 2 | 2020 | 168 | 0.290 |
Why?
| | Aminopeptidases | 2 | 2024 | 14 | 0.290 |
Why?
| | Xenograft Model Antitumor Assays | 4 | 2024 | 813 | 0.290 |
Why?
| | Drosophila melanogaster | 1 | 2009 | 217 | 0.280 |
Why?
| | Databases, Genetic | 3 | 2018 | 228 | 0.280 |
Why?
| | Mice | 19 | 2025 | 16644 | 0.280 |
Why?
| | DNA Helicases | 2 | 2021 | 149 | 0.270 |
Why?
| | Prostatic Neoplasms, Castration-Resistant | 2 | 2017 | 45 | 0.270 |
Why?
| | Signal Transduction | 8 | 2025 | 4838 | 0.250 |
Why?
| | Oncogene Proteins, Fusion | 3 | 2023 | 198 | 0.240 |
Why?
| | Promoter Regions, Genetic | 6 | 2021 | 1200 | 0.240 |
Why?
| | Meta-Analysis as Topic | 2 | 2023 | 169 | 0.230 |
Why?
| | Chemokine CCL2 | 1 | 2025 | 118 | 0.230 |
Why?
| | Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2025 | 43 | 0.230 |
Why?
| | Epigenesis, Genetic | 3 | 2020 | 616 | 0.230 |
Why?
| | Epithelial-Mesenchymal Transition | 3 | 2021 | 199 | 0.230 |
Why?
| | Pancreatic Neoplasms | 2 | 2023 | 878 | 0.230 |
Why?
| | ACTH-Secreting Pituitary Adenoma | 1 | 2024 | 11 | 0.230 |
Why?
| | Cholangiocarcinoma | 1 | 2024 | 77 | 0.210 |
Why?
| | Bile Duct Neoplasms | 1 | 2024 | 99 | 0.210 |
Why?
| | Organoids | 1 | 2024 | 105 | 0.210 |
Why?
| | Neuroendocrine Tumors | 1 | 2024 | 99 | 0.210 |
Why?
| | Datasets as Topic | 1 | 2023 | 110 | 0.210 |
Why?
| | Proteomics | 3 | 2021 | 1010 | 0.210 |
Why?
| | Nuclear Proteins | 2 | 2020 | 660 | 0.200 |
Why?
| | Female | 22 | 2025 | 68517 | 0.200 |
Why?
| | MDS1 and EVI1 Complex Locus Protein | 1 | 2022 | 6 | 0.200 |
Why?
| | Sarcoma, Ewing | 1 | 2023 | 88 | 0.190 |
Why?
| | Killer Cells, Natural | 1 | 2025 | 426 | 0.190 |
Why?
| | Interleukin-13 Receptor alpha2 Subunit | 1 | 2021 | 5 | 0.190 |
Why?
| | Neoplasm Invasiveness | 3 | 2018 | 480 | 0.190 |
Why?
| | ROC Curve | 2 | 2021 | 502 | 0.190 |
Why?
| | Melanoma | 2 | 2023 | 752 | 0.190 |
Why?
| | Muscle Development | 1 | 2022 | 103 | 0.180 |
Why?
| | NF-kappa B | 1 | 2025 | 652 | 0.180 |
Why?
| | Cell Proliferation | 8 | 2021 | 2347 | 0.180 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2023 | 215 | 0.180 |
Why?
| | ADAM10 Protein | 1 | 2021 | 30 | 0.180 |
Why?
| | Receptors, CCR2 | 1 | 2020 | 37 | 0.180 |
Why?
| | Carcinoma, Lobular | 1 | 2021 | 48 | 0.180 |
Why?
| | Asymptomatic Diseases | 1 | 2021 | 85 | 0.180 |
Why?
| | Gamma Rays | 1 | 2021 | 52 | 0.180 |
Why?
| | Gene Ontology | 1 | 2020 | 48 | 0.180 |
Why?
| | PAX3 Transcription Factor | 1 | 2020 | 11 | 0.180 |
Why?
| | Proto-Oncogene Protein c-ets-1 | 1 | 2020 | 19 | 0.180 |
Why?
| | Radiosurgery | 1 | 2023 | 318 | 0.170 |
Why?
| | Forkhead Box Protein O1 | 1 | 2020 | 21 | 0.170 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2021 | 81 | 0.170 |
Why?
| | Wnt Signaling Pathway | 1 | 2022 | 166 | 0.170 |
Why?
| | Cytoreduction Surgical Procedures | 1 | 2020 | 61 | 0.170 |
Why?
| | Neoplasm Recurrence, Local | 3 | 2023 | 963 | 0.170 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2020 | 60 | 0.170 |
Why?
| | Radiation Injuries | 1 | 2021 | 137 | 0.160 |
Why?
| | Tumor Microenvironment | 2 | 2020 | 622 | 0.160 |
Why?
| | Receptors, Interferon | 1 | 2019 | 50 | 0.160 |
Why?
| | Homologous Recombination | 1 | 2019 | 23 | 0.160 |
Why?
| | Small Molecule Libraries | 1 | 2020 | 86 | 0.160 |
Why?
| | RNA Interference | 1 | 2021 | 441 | 0.160 |
Why?
| | Discoidin Domain Receptor 2 | 1 | 2019 | 3 | 0.160 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2020 | 376 | 0.160 |
Why?
| | Cytokines | 2 | 2024 | 1987 | 0.160 |
Why?
| | Cell Differentiation | 3 | 2022 | 1901 | 0.160 |
Why?
| | Trisomy | 1 | 2019 | 77 | 0.160 |
Why?
| | CD8-Positive T-Lymphocytes | 3 | 2020 | 847 | 0.160 |
Why?
| | Kynurenine | 1 | 2019 | 105 | 0.150 |
Why?
| | Dasatinib | 1 | 2019 | 51 | 0.150 |
Why?
| | Prognosis | 7 | 2021 | 3788 | 0.150 |
Why?
| | Reproducibility of Results | 2 | 2023 | 3033 | 0.150 |
Why?
| | Chloroquine | 1 | 2018 | 52 | 0.150 |
Why?
| | SOXB1 Transcription Factors | 1 | 2019 | 58 | 0.150 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 391 | 0.150 |
Why?
| | Neoplasm Proteins | 2 | 2018 | 421 | 0.150 |
Why?
| | Molecular Conformation | 1 | 2018 | 139 | 0.150 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 2 | 2023 | 129 | 0.150 |
Why?
| | Receptors, Estrogen | 1 | 2021 | 429 | 0.150 |
Why?
| | Fibrosis | 1 | 2021 | 522 | 0.150 |
Why?
| | Microbiota | 2 | 2023 | 720 | 0.150 |
Why?
| | Neoplasms, Experimental | 1 | 2019 | 169 | 0.150 |
Why?
| | Macrolides | 1 | 2018 | 62 | 0.150 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2020 | 215 | 0.150 |
Why?
| | Monte Carlo Method | 1 | 2018 | 138 | 0.150 |
Why?
| | Lysosomes | 1 | 2018 | 136 | 0.140 |
Why?
| | Neoadjuvant Therapy | 1 | 2020 | 381 | 0.140 |
Why?
| | Histone Code | 1 | 2017 | 31 | 0.140 |
Why?
| | Probability | 1 | 2018 | 308 | 0.140 |
Why?
| | Machine Learning | 2 | 2022 | 447 | 0.140 |
Why?
| | Cell Cycle Proteins | 1 | 2021 | 580 | 0.140 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2020 | 431 | 0.140 |
Why?
| | Immunity, Cellular | 1 | 2019 | 267 | 0.140 |
Why?
| | Cell Death | 1 | 2018 | 348 | 0.140 |
Why?
| | DNA Damage | 1 | 2019 | 364 | 0.140 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2019 | 227 | 0.140 |
Why?
| | Data Interpretation, Statistical | 2 | 2009 | 335 | 0.140 |
Why?
| | Adenocarcinoma | 1 | 2023 | 889 | 0.130 |
Why?
| | Histidine Kinase | 1 | 2016 | 33 | 0.130 |
Why?
| | CD24 Antigen | 1 | 2016 | 20 | 0.130 |
Why?
| | YY1 Transcription Factor | 1 | 2016 | 28 | 0.130 |
Why?
| | Nomograms | 1 | 2016 | 47 | 0.130 |
Why?
| | Urologic Neoplasms | 1 | 2016 | 25 | 0.130 |
Why?
| | Transcriptional Activation | 1 | 2018 | 356 | 0.130 |
Why?
| | B7-H1 Antigen | 1 | 2018 | 189 | 0.130 |
Why?
| | Sulfonamides | 1 | 2020 | 500 | 0.130 |
Why?
| | Organizational Innovation | 2 | 2016 | 140 | 0.130 |
Why?
| | Drug Delivery Systems | 1 | 2019 | 326 | 0.130 |
Why?
| | Deoxycytidine | 1 | 2017 | 164 | 0.130 |
Why?
| | Adenosine Triphosphatases | 1 | 2016 | 161 | 0.120 |
Why?
| | DNA Methylation | 2 | 2017 | 605 | 0.120 |
Why?
| | Genetic Heterogeneity | 1 | 2015 | 57 | 0.120 |
Why?
| | rho Guanine Nucleotide Dissociation Inhibitor beta | 1 | 2014 | 4 | 0.120 |
Why?
| | Up-Regulation | 1 | 2018 | 828 | 0.120 |
Why?
| | Bayes Theorem | 3 | 2023 | 372 | 0.120 |
Why?
| | Telomere Homeostasis | 1 | 2015 | 28 | 0.120 |
Why?
| | Ovarian Neoplasms | 1 | 2020 | 490 | 0.120 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 568 | 0.120 |
Why?
| | Alleles | 1 | 2017 | 845 | 0.120 |
Why?
| | Survival Rate | 4 | 2021 | 1875 | 0.120 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 386 | 0.120 |
Why?
| | Histone Demethylases | 1 | 2014 | 31 | 0.110 |
Why?
| | Membrane Proteins | 1 | 2021 | 1109 | 0.110 |
Why?
| | Immunotherapy | 1 | 2019 | 588 | 0.110 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2014 | 42 | 0.110 |
Why?
| | rho GTP-Binding Proteins | 1 | 2014 | 62 | 0.110 |
Why?
| | Tomography, X-Ray Computed | 1 | 2024 | 2541 | 0.110 |
Why?
| | Transcription, Genetic | 3 | 2017 | 1403 | 0.110 |
Why?
| | Ornithine Decarboxylase Inhibitors | 1 | 2013 | 3 | 0.110 |
Why?
| | Phylogeny | 3 | 2023 | 846 | 0.110 |
Why?
| | Anabolic Agents | 1 | 2013 | 12 | 0.110 |
Why?
| | High-Throughput Screening Assays | 1 | 2015 | 136 | 0.110 |
Why?
| | Models, Theoretical | 1 | 2017 | 546 | 0.110 |
Why?
| | International Cooperation | 1 | 2014 | 173 | 0.110 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2716 | 0.110 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2022 | 818 | 0.110 |
Why?
| | Drug Synergism | 1 | 2014 | 358 | 0.110 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2018 | 703 | 0.110 |
Why?
| | Databases, Protein | 2 | 2014 | 61 | 0.110 |
Why?
| | Organ Sparing Treatments | 1 | 2013 | 32 | 0.110 |
Why?
| | Phenotype | 2 | 2020 | 3058 | 0.110 |
Why?
| | Microsatellite Repeats | 1 | 2014 | 162 | 0.110 |
Why?
| | Epigenomics | 1 | 2014 | 111 | 0.110 |
Why?
| | Infant, Newborn | 2 | 2023 | 5739 | 0.110 |
Why?
| | Drug Combinations | 1 | 2014 | 329 | 0.110 |
Why?
| | Arthritis, Rheumatoid | 1 | 2022 | 1109 | 0.110 |
Why?
| | Models, Molecular | 1 | 2018 | 1483 | 0.110 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2020 | 592 | 0.100 |
Why?
| | Cluster Analysis | 2 | 2016 | 478 | 0.100 |
Why?
| | Models, Statistical | 1 | 2016 | 626 | 0.100 |
Why?
| | Superoxides | 1 | 2013 | 196 | 0.100 |
Why?
| | Brain Neoplasms | 1 | 2021 | 1164 | 0.100 |
Why?
| | Cyclin-Dependent Kinase 4 | 1 | 2012 | 42 | 0.100 |
Why?
| | Integrins | 2 | 2023 | 92 | 0.100 |
Why?
| | Community-Institutional Relations | 1 | 2013 | 96 | 0.100 |
Why?
| | Pregnancy | 2 | 2023 | 6375 | 0.100 |
Why?
| | Magnetic Resonance Imaging | 1 | 2024 | 3383 | 0.100 |
Why?
| | Prostate | 1 | 2013 | 178 | 0.100 |
Why?
| | Biomarkers | 2 | 2021 | 3896 | 0.100 |
Why?
| | Apoptosis | 3 | 2021 | 2438 | 0.100 |
Why?
| | Tumor Suppressor Proteins | 1 | 2014 | 313 | 0.100 |
Why?
| | Software | 2 | 2014 | 610 | 0.100 |
Why?
| | Genome-Wide Association Study | 1 | 2018 | 1337 | 0.090 |
Why?
| | Genome, Insect | 2 | 2009 | 21 | 0.090 |
Why?
| | Male | 11 | 2024 | 63201 | 0.090 |
Why?
| | Alternative Splicing | 1 | 2013 | 218 | 0.090 |
Why?
| | B-Lymphocytes | 2 | 2014 | 823 | 0.090 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 259 | 0.090 |
Why?
| | Saccharomyces cerevisiae | 3 | 2012 | 525 | 0.090 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 5284 | 0.090 |
Why?
| | MCF-7 Cells | 2 | 2021 | 115 | 0.090 |
Why?
| | Reactive Oxygen Species | 1 | 2013 | 579 | 0.090 |
Why?
| | Enzyme Inhibitors | 1 | 2013 | 811 | 0.090 |
Why?
| | Hematopoietic Stem Cells | 1 | 2013 | 378 | 0.080 |
Why?
| | Horns | 1 | 2009 | 1 | 0.080 |
Why?
| | Genetic Predisposition to Disease | 1 | 2018 | 2267 | 0.080 |
Why?
| | Testosterone | 1 | 2013 | 379 | 0.080 |
Why?
| | Pseudogenes | 1 | 2009 | 18 | 0.080 |
Why?
| | Expressed Sequence Tags | 1 | 2009 | 41 | 0.080 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2012 | 322 | 0.080 |
Why?
| | Inflammation | 1 | 2020 | 2668 | 0.080 |
Why?
| | Systems Integration | 1 | 2009 | 40 | 0.080 |
Why?
| | Drug Discovery | 2 | 2022 | 130 | 0.080 |
Why?
| | Coleoptera | 1 | 2009 | 27 | 0.080 |
Why?
| | Models, Genetic | 2 | 2009 | 591 | 0.080 |
Why?
| | Stem Cells | 1 | 2013 | 579 | 0.080 |
Why?
| | Genes, Fungal | 1 | 2009 | 51 | 0.080 |
Why?
| | Genetic Diseases, Inborn | 1 | 2008 | 38 | 0.070 |
Why?
| | Tumor Cells, Cultured | 2 | 2021 | 930 | 0.070 |
Why?
| | Genes, Insect | 1 | 2007 | 21 | 0.070 |
Why?
| | Gene Deletion | 1 | 2009 | 372 | 0.070 |
Why?
| | Zebrafish | 2 | 2022 | 464 | 0.070 |
Why?
| | Combined Modality Therapy | 2 | 2020 | 1209 | 0.070 |
Why?
| | BRCA1 Protein | 2 | 2020 | 65 | 0.070 |
Why?
| | Disease | 1 | 2008 | 94 | 0.070 |
Why?
| | Genetics, Population | 1 | 2008 | 200 | 0.070 |
Why?
| | Neoplasm Staging | 2 | 2024 | 1293 | 0.070 |
Why?
| | Genome, Human | 1 | 2009 | 392 | 0.070 |
Why?
| | Mitochondria | 1 | 2013 | 854 | 0.070 |
Why?
| | Oxidative Stress | 1 | 2013 | 1192 | 0.070 |
Why?
| | Selection, Genetic | 1 | 2008 | 250 | 0.070 |
Why?
| | Prednisone | 2 | 2017 | 236 | 0.060 |
Why?
| | Adult | 4 | 2024 | 35512 | 0.060 |
Why?
| | Chromatin | 2 | 2022 | 478 | 0.060 |
Why?
| | Follow-Up Studies | 3 | 2020 | 4915 | 0.060 |
Why?
| | T-Lymphocytes | 1 | 2013 | 1924 | 0.060 |
Why?
| | Aged | 5 | 2024 | 22089 | 0.060 |
Why?
| | Cell Line | 3 | 2019 | 2737 | 0.060 |
Why?
| | Base Sequence | 3 | 2017 | 2135 | 0.060 |
Why?
| | Evolution, Molecular | 1 | 2007 | 467 | 0.050 |
Why?
| | Proto-Oncogene Protein c-fli-1 | 1 | 2023 | 23 | 0.050 |
Why?
| | RNA-Binding Protein EWS | 1 | 2023 | 23 | 0.050 |
Why?
| | Cell Movement | 2 | 2021 | 939 | 0.050 |
Why?
| | BCG Vaccine | 1 | 2023 | 24 | 0.050 |
Why?
| | Internet | 1 | 2008 | 620 | 0.050 |
Why?
| | Anti-Bacterial Agents | 1 | 2013 | 1671 | 0.050 |
Why?
| | Cells, Cultured | 3 | 2016 | 4010 | 0.050 |
Why?
| | Protein Binding | 2 | 2020 | 2106 | 0.050 |
Why?
| | Biological Assay | 1 | 2023 | 118 | 0.050 |
Why?
| | Mice, Nude | 2 | 2016 | 683 | 0.050 |
Why?
| | Pituitary Neoplasms | 1 | 2024 | 184 | 0.050 |
Why?
| | Myogenin | 1 | 2022 | 13 | 0.050 |
Why?
| | Proteins | 1 | 2008 | 936 | 0.050 |
Why?
| | MyoD Protein | 1 | 2022 | 32 | 0.050 |
Why?
| | Rhabdomyosarcoma, Embryonal | 1 | 2022 | 20 | 0.050 |
Why?
| | Adjuvants, Immunologic | 1 | 2023 | 221 | 0.050 |
Why?
| | Vagina | 1 | 2023 | 176 | 0.050 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2022 | 87 | 0.050 |
Why?
| | Cell Lineage | 2 | 2013 | 334 | 0.050 |
Why?
| | Contrast Media | 1 | 2024 | 388 | 0.050 |
Why?
| | Chondrogenesis | 1 | 2022 | 82 | 0.050 |
Why?
| | Mice, Knockout | 2 | 2022 | 2765 | 0.050 |
Why?
| | Phenylthiohydantoin | 1 | 2021 | 44 | 0.050 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2022 | 102 | 0.050 |
Why?
| | Wnt Proteins | 1 | 2022 | 126 | 0.050 |
Why?
| | Skull | 1 | 2022 | 129 | 0.040 |
Why?
| | Neural Crest | 1 | 2022 | 120 | 0.040 |
Why?
| | Ephrin-B2 | 1 | 2021 | 50 | 0.040 |
Why?
| | Nitriles | 1 | 2021 | 161 | 0.040 |
Why?
| | Cartilage | 1 | 2022 | 180 | 0.040 |
Why?
| | Benzamides | 1 | 2021 | 195 | 0.040 |
Why?
| | Breast | 1 | 2021 | 153 | 0.040 |
Why?
| | Tamoxifen | 1 | 2021 | 200 | 0.040 |
Why?
| | beta Catenin | 1 | 2022 | 219 | 0.040 |
Why?
| | Melanoma, Experimental | 1 | 2020 | 110 | 0.040 |
Why?
| | Quinolinic Acid | 1 | 2019 | 8 | 0.040 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2020 | 131 | 0.040 |
Why?
| | Biosynthetic Pathways | 1 | 2019 | 23 | 0.040 |
Why?
| | Chondrocytes | 1 | 2022 | 203 | 0.040 |
Why?
| | Androgens | 1 | 2021 | 174 | 0.040 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 52 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 163 | 0.040 |
Why?
| | Young Adult | 3 | 2024 | 12389 | 0.040 |
Why?
| | Nanog Homeobox Protein | 1 | 2019 | 13 | 0.040 |
Why?
| | Enhancer Elements, Genetic | 1 | 2020 | 179 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2023 | 1865 | 0.040 |
Why?
| | Inhibitor of Differentiation Proteins | 1 | 2018 | 2 | 0.040 |
Why?
| | Cell Cycle | 1 | 2021 | 581 | 0.040 |
Why?
| | Mice, SCID | 1 | 2019 | 347 | 0.040 |
Why?
| | Enhancer of Zeste Homolog 2 Protein | 1 | 2017 | 41 | 0.040 |
Why?
| | 5-Methylcytosine | 1 | 2017 | 20 | 0.040 |
Why?
| | Kaplan-Meier Estimate | 1 | 2020 | 864 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2020 | 428 | 0.040 |
Why?
| | CpG Islands | 1 | 2017 | 152 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2023 | 872 | 0.030 |
Why?
| | Middle Aged | 4 | 2024 | 31079 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 584 | 0.030 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2017 | 63 | 0.030 |
Why?
| | Co-Repressor Proteins | 1 | 2016 | 16 | 0.030 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2016 | 39 | 0.030 |
Why?
| | Taxoids | 1 | 2016 | 95 | 0.030 |
Why?
| | Chromosome Deletion | 1 | 2016 | 102 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2016 | 157 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1230 | 0.030 |
Why?
| | Heterografts | 1 | 2016 | 129 | 0.030 |
Why?
| | Logistic Models | 1 | 2021 | 1979 | 0.030 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 256 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 312 | 0.030 |
Why?
| | DNA Copy Number Variations | 1 | 2016 | 169 | 0.030 |
Why?
| | Interdisciplinary Communication | 1 | 2016 | 187 | 0.030 |
Why?
| | rhoC GTP-Binding Protein | 1 | 2014 | 6 | 0.030 |
Why?
| | Exome | 1 | 2016 | 220 | 0.030 |
Why?
| | Protein Domains | 1 | 2016 | 252 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 2016 | 505 | 0.030 |
Why?
| | Zinc Finger E-box Binding Homeobox 2 | 1 | 2014 | 5 | 0.030 |
Why?
| | Sequence Analysis, DNA | 2 | 2008 | 773 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2016 | 2065 | 0.030 |
Why?
| | Urothelium | 1 | 2015 | 37 | 0.030 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2014 | 52 | 0.030 |
Why?
| | Survival Analysis | 1 | 2017 | 1265 | 0.030 |
Why?
| | Metabolomics | 1 | 2019 | 599 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2020 | 1048 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1462 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2009 | 2819 | 0.030 |
Why?
| | Neoplasm Transplantation | 1 | 2014 | 258 | 0.030 |
Why?
| | Sequence Analysis, Protein | 1 | 2014 | 28 | 0.030 |
Why?
| | Ornithine Decarboxylase | 1 | 2013 | 9 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2016 | 357 | 0.030 |
Why?
| | Eflornithine | 1 | 2013 | 4 | 0.030 |
Why?
| | Follistatin | 1 | 2013 | 12 | 0.030 |
Why?
| | Neoplasm Grading | 1 | 2015 | 284 | 0.030 |
Why?
| | Point Mutation | 1 | 2015 | 224 | 0.030 |
Why?
| | Intrinsically Disordered Proteins | 1 | 2014 | 30 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2023 | 2508 | 0.030 |
Why?
| | Amino Acid Motifs | 1 | 2014 | 209 | 0.030 |
Why?
| | Blotting, Western | 1 | 2016 | 1169 | 0.030 |
Why?
| | Protein Conformation | 1 | 2016 | 853 | 0.030 |
Why?
| | Aminoglycosides | 1 | 2013 | 21 | 0.030 |
Why?
| | Area Under Curve | 1 | 2014 | 282 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2016 | 380 | 0.030 |
Why?
| | beta-Lactams | 1 | 2013 | 26 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1021 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2015 | 799 | 0.030 |
Why?
| | Organ Size | 1 | 2013 | 441 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2017 | 1000 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2016 | 485 | 0.030 |
Why?
| | Databases, Factual | 1 | 2018 | 1279 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2017 | 10226 | 0.020 |
Why?
| | Doxycycline | 1 | 2012 | 55 | 0.020 |
Why?
| | Genes, ras | 1 | 2012 | 98 | 0.020 |
Why?
| | Bone Marrow Transplantation | 1 | 2013 | 268 | 0.020 |
Why?
| | Cell Cycle Checkpoints | 1 | 2012 | 95 | 0.020 |
Why?
| | Antigens, CD | 1 | 2014 | 483 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2013 | 308 | 0.020 |
Why?
| | Quinolones | 1 | 2013 | 127 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 816 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2014 | 400 | 0.020 |
Why?
| | Benzimidazoles | 1 | 2012 | 158 | 0.020 |
Why?
| | DNA | 1 | 2017 | 1392 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2013 | 471 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2013 | 1284 | 0.020 |
Why?
| | Pupa | 1 | 2009 | 10 | 0.020 |
Why?
| | Gene Library | 1 | 2009 | 116 | 0.020 |
Why?
| | Body Weight | 1 | 2013 | 932 | 0.020 |
Why?
| | Cell Survival | 1 | 2012 | 1077 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2013 | 1671 | 0.020 |
Why?
| | Larva | 1 | 2009 | 211 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2079 | 0.020 |
Why?
| | Escherichia coli | 1 | 2012 | 771 | 0.020 |
Why?
| | Staphylococcus aureus | 1 | 2012 | 431 | 0.020 |
Why?
| | Adolescent | 2 | 2017 | 20301 | 0.020 |
Why?
| | Synteny | 1 | 2007 | 16 | 0.020 |
Why?
| | Gene Order | 1 | 2007 | 26 | 0.020 |
Why?
| | Genome, Mitochondrial | 1 | 2007 | 27 | 0.020 |
Why?
| | Codon | 1 | 2007 | 86 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2613 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2015 | 2676 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2007 | 330 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 9768 | 0.020 |
Why?
| | Multigene Family | 1 | 2007 | 198 | 0.020 |
Why?
| | Immunity | 1 | 2007 | 132 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 6518 | 0.020 |
Why?
| | DNA Transposable Elements | 1 | 2007 | 119 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2024 | 14571 | 0.020 |
Why?
| | Terminology as Topic | 1 | 2008 | 200 | 0.020 |
Why?
| | RNA, Untranslated | 1 | 2007 | 114 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2017 | 7065 | 0.020 |
Why?
| | Reproduction | 1 | 2007 | 201 | 0.020 |
Why?
| | Drosophila Proteins | 1 | 2007 | 187 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 1640 | 0.010 |
Why?
| | Child | 1 | 2023 | 20805 | 0.010 |
Why?
| | RNA | 1 | 2008 | 883 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2008 | 3953 | 0.010 |
Why?
|
|
Costello's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|